Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn’s fistula
Institut National de la Santé et de la Recherche Médicale
Université de Toulouse
Direction Générale de l’offre de Soins
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn’s fistula
Adrian Culetto, Isabelle Quelven, Fatima Zahra Mokrane, Guillaume Le Cosquer et al.
Journal
BMJ Open
Topics
Anorectal Disease Treatments and Outcomes
article
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn’s fistula
Adrian Culetto, Isabelle Quelven, Fatima Zahra Mokrane, Guillaume Le Cosquer, Marine Lebrin, Benoît Lepage, Louis Buscail, Barbara Bournet, Étienne Buscail, Charline Daguzan, Laurent Ghouti, Cyrielle Gilletta, Antoine Philis, Fabian Gross, G. Pugnet, Marie Charlotte Delchier, Nicolas Carrère, J.P. Duffas, Ines Frument
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(12)
Institutions
Université Fédérale de Toulouse Midi-Pyrénées (FR), Centre Hospitalier Universitaire de Toulouse (FR), Institut de Recherche en Santé Digestive (FR), Clinique Pasteur (FR)
Funders
Institut National de la Santé et de la Recherche Médicale, Université de Toulouse, Direction Générale de l’offre de Soins
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn’s fistula — Adrian Culetto, Isabelle Quelven, et al. · BMJ Open (2025) | TGRS Research Map | TGRS